Maybe we get some good news and nice surprises more regularly over the coming months. Seems the company is flagging PW will stand down at some point. I imagine he needs a change, new challenge or a rest. Hope it a gradual process and perhaps a seat on the board? End of quarter sales will hopefully show some significant USA sales and revenue as the next catalyst. Once the phase 2 XP trial commences, it will give some more safety data in a new sensitive cohort. Also looking forward to the penumbra targets. Perhaps a couple of months away? They have been flagging some inorganic growth for some time now so I imagine they know what they are after and will take an opportunity should it arise. I don’t see any negatives but then that’s half glass full for you!! GLTA
Ann: Presentation - Value in the Vines Investor Conference, page-3
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.12 |
Change
0.250(1.80%) |
Mkt cap ! $706.8M | |||
| Open | High | Low | Value | Volume |
| $13.90 | $14.17 | $13.90 | $675.2K | 48.01K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 293 | $14.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.12 | 261 | 1 |
View Market Depth
| Last trade - 16.10pm 11/10/2024 (20 minute delay) ? |
| CUV (ASX) Chart |